US Stock Movement | Replimune Rises Another 12% in Pre-market as Late-stage Melanoma Drug Application Sees Breakthrough
Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
Golden Ten Data June 1｜Last Friday (May 29), Replimune (REPL.US) soared 85.68%, and today it continues to rise by 12.54% in pre-market trading, reaching $9.78. In the latest news, Replimune stated in a declaration that it has "agreed on a path forward" with the U.S. Food and Drug Administration (FDA) and will resubmit its application for its late-stage melanoma treatment drug, with the FDA promising to treat this review as an "urgent matter." Previously, in April this year, the FDA rejected Replimune's combination therapy for late-stage melanoma for the second time.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
Analyst: Market Could See 'Excluding SpaceX' Index ETF, but Demand Expected to be Limited
BlockBeats•2026/06/01 11:56
Goldman Sachs Reiterates Buy Rating and $285 Target Price for Nvidia
Cointime•2026/06/01 11:52
Trending news
MoreCrypto prices
More
Bitcoin
BTC
$72,588.95
-1.66%
Ethereum
ETH
$1,981.13
-1.90%
Tether USDt
USDT
$0.9988
+0.02%
BNB
BNB
$695.66
-3.62%
XRP
XRP
$1.3
-2.73%
USDC
USDC
$0.9996
-0.01%
Solana
SOL
$80.79
-2.20%
TRON
TRX
$0.3497
+0.39%
Hyperliquid
HYPE
$73.47
+8.52%
Dogecoin
DOGE
$0.09992
-0.70%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now